AGPU AGPU Drug Discovery Services — Cost of Goods Sold

Other segment segments

Similar metrics at other companies

LQD

LQDAProduct — Cost of Goods Sold

$11.08M—

OPKPharmaceutical — Cost of Goods Sold

$22.3M-2.3%

STIMProduct — Cost of Goods Sold

$2.86M-9.3%

STIMClinical Services — Cost of Goods Sold

$15.44M+18.0%

OMProduct — Cost of Goods Sold

$8.83M-19.7%

FSICost of Goods Sold

$6.41M+16.0%

Questions, answered.

What is AGPU's drug discovery services — cost of goods sold?

AGPU (AGPU) reported drug discovery services — cost of goods sold of $1.01M in Q1 2026.

How has AGPU's drug discovery services — cost of goods sold changed year-over-year?

AGPU's drug discovery services — cost of goods sold increased by 3.0% year-over-year, from $977.73K to $1.01M.

What does drug discovery services — cost of goods sold mean?

Includes the direct costs attributable to the production and delivery of drug discovery services, such as labor, materials, and laboratory overhead. Monitoring this metric is critical for evaluating the segment's gross margin and operational efficiency. It provides insight into the cost-effectiveness of the segment's service delivery model.